Pasithea Therapeutics Corp

General ticker "KTTA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.0M

Pasithea Therapeutics Corp does not follow the US Stock Market performance with the rate: -45.3%.

Estimated limits based on current volatility of 4.1%: low 2.50$, high 2.72$

Factors to consider:

  • Earnings expected soon, date: nan
  • Current price 36.8% below estimated low
  • Earnings for 18 months up through Q2 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [6.23$, 15.39$]
  • 2023-12-31 to 2024-12-30 estimated range: [4.21$, 10.60$]

Similar symbols

Short-term KTTA quotes

Long-term KTTA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31
Operating Revenue $0.02MM $0.49MM
Operating Expenses $4.52MM $15.30MM
Operating Income $-4.51MM $-14.82MM
Non-Operating Income $2.33MM $0.88MM
Interest Expense $0.00MM $0.00MM
R&D Expense $0.00MM $2.67MM
Income(Loss) $-2.17MM $-13.94MM
Taxes $0.00MM $-0.88MM
Profit(Loss) $-2.17MM $-13.06MM
Stockholders Equity $51.42MM $42.50MM
Inventory $0.00MM $0.00MM
Assets $53.32MM $45.18MM
Operating Cash Flow $-3.17MM $-14.56MM
Capital expenditure $0.02MM $2.14MM
Investing Cash Flow $-0.02MM $-2.06MM
Financing Cash Flow $55.93MM $-3.21MM
Earnings Per Share* $-1.89 $-10.34

* EPS are Split Adjusted, recent splits may be reflected with a delay.